BioStem Technologies, Inc. (BSEM)
OTCMKTS: BSEM · Delayed Price · USD
8.85
-0.69 (-7.23%)
Jul 19, 2024, 3:59 PM EDT - Market closed

BioStem Technologies Revenue

BioStem Technologies had revenue of $58.01M in the twelve months ending March 31, 2024, with 1,141.52% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $41.90M with 7,173.74% year-over-year growth. In the year 2023, BioStem Technologies had annual revenue of $16.69M with 142.69% growth.

Revenue (ttm)
$58.01M
Revenue Growth
+1,141.52%
P/S Ratio
2.48
Revenue / Employee
$1,657,529
Employees
35
Market Cap
143.61M

Revenue Chart

* This company reports financials in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202316.69M9.81M142.69%
Dec 31, 20226.88M2.53M58.38%
Dec 31, 20214.34M1.82M72.14%
Dec 31, 20202.52M-108.68K-4.13%
Dec 31, 20192.63M1.61M158.59%
Dec 31, 20181.02M688.66K209.62%
Dec 31, 2017328.53K-263.77K-44.53%
Dec 31, 2016592.30K440.76K290.86%
Dec 31, 2015151.54K120.34K385.80%
Dec 31, 201431.19K15.88K103.76%
Dec 31, 201315.31K-791.43K-98.10%
Dec 31, 2012806.74K-556.76K-40.83%
Dec 31, 20111.36M101.12K8.01%
Dec 31, 20101.26M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 379.49B
Johnson & Johnson 81.80B
Merck & Co. 61.40B
AbbVie 54.40B
Novartis AG 48.86B
AstraZeneca 47.61B
Thermo Fisher 42.49B
Eli Lilly 35.93B
Revenue Rankings